Avalo Therapeutics (AVTX) Enterprise Value: -10.85M

Avalo Therapeutics, Inc. (AVTX)

7.15 -0.17 (-2.32%) USD | NASDAQ | Nov 03, 14:13

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2015. Start Trial.

Date	Value
November 02, 2026	-10.85M
October 30, 2026	-18.78M
October 29, 2026	-4.502M
October 28, 2026	-21.43M
October 27, 2026	-41.00M
October 26, 2026	-39.95M
October 23, 2026	-31.48M
October 22, 2026	-3.973M
October 21, 2026	250.48M
October 20, 2026	255.77M
October 19, 2026	215.04M
October 16, 2026	198.11M
October 15, 2026	237.25M
October 14, 2026	228.26M
October 13, 2026	237.25M
October 12, 2026	302.32M
October 09, 2026	324.01M
October 08, 2026	312.37M
October 07, 2026	320.31M
October 06, 2026	320.84M
October 05, 2026	374.27M
October 02, 2026	394.90M
October 01, 2026	392.78M
September 30, 2026	412.88M
September 29, 2026	426.11M

Date	Value
September 28, 2026	399.66M
September 25, 2026	420.29M
September 24, 2026	433.52M
September 23, 2026	411.30M
September 22, 2026	475.31M
September 21, 2026	457.32M
September 18, 2026	478.48M
September 17, 2026	484.83M
September 16, 2026	479.01M
September 15, 2026	452.03M
September 14, 2026	457.85M
September 11, 2026	454.68M
September 10, 2026	510.75M
September 09, 2026	565.24M
September 08, 2026	644.59M
September 04, 2026	619.20M
September 03, 2026	607.03M
September 02, 2026	625.02M
September 01, 2026	604.39M
August 31, 2026	625.02M
August 28, 2026	638.24M
August 27, 2026	662.58M
August 26, 2026	689.03M
August 25, 2026	646.18M
August 24, 2026	621.31M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks